Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Genzyme Predicts $5 Bil. In Annual Revenues By 2010 From Current Portfolio

Jan 10 2006

• By Jessica Merrill

Related Content

Genzyme Myozyme BLA For Pompe Disease Could Clear FDA By January

Jul 29 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window